NCT07181304

Brief Summary

This study will include a type 1 hybrid effectiveness implementation study to evaluate the effectiveness of the PROMOTE (peer support plus remote patient monitoring) program among Black adults with uncontrolled type 2 diabetes recruited from local primary care practices in Jefferson County, Alabama. Additionally, a mixed methods evaluation to characterize the contextual factors relevant to implementation of PROMOTE using Practical Robust Implementation Science Model (PRISM) will be conducted.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable type-2-diabetes

Timeline
25mo left

Started Jun 2026

Typical duration for not_applicable type-2-diabetes

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 18, 2025

Completed
9 months until next milestone

Study Start

First participant enrolled

June 15, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

May 26, 2026

Status Verified

May 1, 2026

Enrollment Period

2 years

First QC Date

September 11, 2025

Last Update Submit

May 22, 2026

Conditions

Keywords

Peer supportRemote patient monitoring

Outcome Measures

Primary Outcomes (1)

  • Change in Hemoglobin A1c (A1C)

    Change in A1C value at 6-months compared to baseline. Lab values will be extracted from electronic health record. Per the American Diabetes Association (ADA) Standards of Care, A1C is recommended to be checked quarterly for patients with type 2 diabetes, whose A1C is not at target level (i.e. the eligibility criteria for this study sample).

    Baseline, 6-months

Secondary Outcomes (3)

  • Change in blood pressure

    Baseline, 6-months

  • Change in Low Density Lipoprotein (LDL)

    Baseline, 6-months

  • Change in Body Mass Index (BMI)

    Baseline, 6-months

Study Arms (2)

PROMOTE

EXPERIMENTAL
Behavioral: PROMOTEBehavioral: DSMES

Control

ACTIVE COMPARATOR
Behavioral: DSMES

Interventions

PROMOTEBEHAVIORAL

PROMOTE components includes 1) peer support, 2) remote patient monitoring of blood glucose (RPM), and 3) integration with clinical care. 1. Peer support delivered by community health workers focused on -- assistance in applying diabetes self-management in daily life, emotional and social support, linkage to clinical care, and ongoing, as-needed support. CHWs visits will include: one-on-one in-person visit, then weekly phone calls for 3 months, then monthly calls for 3 months. 2. RPM team will supply the device and supplies to participants. Data is transmitted electronically to the RPM team through broadband connectivity. Protocols have been developed for research projects; participants will be instructed to monitor blood glucose up to four times a day, based on medication regimen. Levels will be monitored 8 a.m. to 5 p.m. M-F. 3. A monthly report of peer support activities and RPM data will be sent to participants' primary care providers.

PROMOTE
DSMESBEHAVIORAL

Diabetes Self-Management Education and Support delivered virtually.

ControlPROMOTE

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 19 years or older
  • Black race (self-reported)
  • Diagnosis of type 2 diabetes
  • Uncontrolled A1C \>8%
  • Receipt of care at one of the study sites
  • Speaks and reads in English

You may not qualify if:

  • Limited English proficiency
  • Currently pregnancy
  • Non-community dwelling.
  • Speaks and reads in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Caroline Presley, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 11, 2025

First Posted

September 18, 2025

Study Start

June 15, 2026

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

June 30, 2028

Last Updated

May 26, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified Individual Participant Data for the following measures will be restricted with a data use agreement: 1) Biometric and lab data including hemoglobin A1c, height, weight, body mass index, blood pressure, remote monitoring of blood glucose; 2) Demographics and health status per NIH required common data elements; 3) Survey assessment: Diabetes Distress Scale, Patient Health Questionnaire, Diabetes Self-Management Questionnaire, Diabetes Self-Efficacy, and Social Support

Shared Documents
STUDY PROTOCOL